Comprehensive Cell Solutions (CCS)

Comprehensive Cell Solutions (CCS) is a leading biotechnology research organization dedicated to advancing cell and gene therapy development and manufacturing. As a business division of the New York Blood Center Enterprises, Comprehensive Cell Solutions (CCS) leverages world-class expertise in clinical trials management, regulatory affairs, and accreditation to meet the evolving needs of academic institutions, hospitals, biotech firms, pharmaceutical companies, and startups. Located at 310 E 67th Street, New York, New York 10065, US, CCS collaborates with diverse entities to manage clinical trials, offering assistance with budget planning, contracts, IRB submissions, FDA submissions, and invoicing.

Comprehensive Cell Solutions (CCS) offers an extensive suite of R&D products and services designed to facilitate partnerships, innovation, and joint ventures. With a focus on pioneering research and development in blood and cell-based therapies, Comprehensive Cell Solutions (CCS) addresses critical, unmet patient needs and seeks to expand its customer base through innovative solutions. The team at CCS has reviewed and overseen numerous research projects, preclinical studies, and clinical trials.

Comprehensive Cell Solutions (CCS) is committed to becoming a world-renowned pioneer in the development of new-generation blood and cell-based therapies. Comprehensive Cell Solutions (CCS) is your partner in simplifying clinical and research challenges. We invite the manager of Comprehensive Cell Solutions (CCS) to create a customized and exclusive company showcase and product listing on our platform to further highlight your exceptional offerings.